about
Intestinal inflammation and the diet: Is food friend or foe?Role of viruses and bacteria-virus interactions in autoimmunityResearch Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's DiseaseNew insights into therapeutic strategies for gut microbiota modulation in inflammatory diseasesIdentification of proteins involved in the anti-inflammatory properties of Propionibacterium freudenreichii by means of a multi-strain studyRole of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?Anatomical localization of commensal bacteria in immune cell homeostasis and diseaseFusobacterium is associated with colorectal adenomasComparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study.Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Duodenal-mucosal bacteria associated with celiac disease in children.Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells.Exploring gut microbes in human health and disease: Pushing the envelope.Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer.Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods.Oral microbiome composition changes in mouse models of colitis.Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acidA novel gastrointestinal microbiome modulator from soy pods reduces absorption of dietary fat in mice.Human microbiome versus food-borne pathogens: friend or foe.Drug-induced inflammatory bowel disease and IBD-like conditions.The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis.Gut microbiota in autoimmunity: potential for clinical applications.The Traveling Microbiome.Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice.Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice.Learned and unlearned concepts in periodontal diagnostics: a 50-year perspective.Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis.Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells.Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.Phagocytosis and Epithelial Cell Invasion by Crohn's Disease-Associated Adherent-Invasive Escherichia coli Are Inhibited by the Anti-inflammatory Drug 6-Mercaptopurine.Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases.
P2860
Q26765223-B69F0CD2-B59A-4EB7-BED5-325FC29D004FQ26829755-0880F156-4418-457C-B1C8-F34F139B4CC2Q28066444-684943AC-5182-4DDA-86C1-7CB5DCF94F6DQ28079638-36F2010A-A855-42C1-91AC-32B596C5A545Q33560044-EABE7116-DE0A-41E3-BDB0-2EB5CD4ED158Q34407175-ABFE942E-D1F6-4C6C-A261-734D75AAD966Q34425509-93457969-F4A8-4B4A-880A-9478CDF3C0EDQ34555713-5E3E78BE-F850-42FF-960F-1CA9537AA1AAQ34768443-2C175DA1-20F5-4820-B316-3309B495C690Q34786166-89CAB5F2-1682-41BF-98E7-160A83A15962Q34802876-FC51FB82-83B8-48A4-A5D4-2BB7E37A616FQ35018358-399C01DA-91A0-47B5-A3C9-584AEE7961C1Q35024999-06085FAB-4C71-4DA7-9E6D-B3740BA64320Q35113328-65F2B356-ADAA-410F-91BC-6376E8F8BB6CQ35209892-F0852AB1-6B26-40D9-B34C-ABBEB92E2E24Q35236727-B750C1A0-8365-4829-A1EE-EFC4F168DF20Q35742145-6DFF2787-9883-4815-837A-8B299124D6BFQ35846248-C635B25C-72E9-43F6-9C82-EAF303F8512EQ35996428-4625A089-61A6-4F9C-BE80-CBAE036003DFQ38008983-E51FA2D1-9A95-4459-A03A-DC1E07BD6C41Q38648792-0F11BAAB-71C4-4483-B497-6C586E22564CQ38798347-DE6B1481-2B2F-4AD3-98EF-5EF3A714D2E3Q38839123-1D6A24CC-E064-4757-8AD2-CC211DE8A89DQ38905594-39607ADF-38D2-47E1-9A61-6E7C6216FFFBQ39185571-0C73C6C8-3E66-4AE6-A61F-556D2729F966Q40041978-B799A3E4-CA83-4637-BB85-1E57BB241643Q40447506-3E8E903A-ECB5-41D6-9B1E-A64535EB6640Q45658610-40C75CBD-B8BA-4E5F-9A4F-468EAFED4B54Q49733575-01295609-22E8-4C7A-9CB2-AE1EB6BE9D68Q50899710-6DF8EF25-DCCB-41E0-A288-85106E48F2F1Q51450213-09C5C2AF-D59C-48D1-B4F6-77A3A07B3648Q51600247-20C6684A-E9A0-4C2B-888F-4A723A189309Q55085414-8FE9FCE5-CC74-45CE-808E-F3BE06BE9AA6Q55195884-5D0094BE-65DB-4A09-A490-8925BAF6BD6E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Intestinal dysbiosis in inflammatory bowel disease.
@en
Intestinal dysbiosis in inflammatory bowel disease.
@nl
type
label
Intestinal dysbiosis in inflammatory bowel disease.
@en
Intestinal dysbiosis in inflammatory bowel disease.
@nl
prefLabel
Intestinal dysbiosis in inflammatory bowel disease.
@en
Intestinal dysbiosis in inflammatory bowel disease.
@nl
P2093
P356
P1433
P1476
Intestinal dysbiosis in inflammatory bowel disease.
@en
P2093
Chun-Chia Chen
Jay Luther
John Y Kao
Nirmal Kaur
P304
P356
10.4161/GMIC.2.4.17863
P577
2011-07-01T00:00:00Z